Age-related loss of brain volume and T2 relaxation time in youth with type 1 diabetes

Diabetes Care

Volumn 35, Issue 3, 2012, Pages 513-519

  Pell, Gaby S ^a   Lin, Ashleigh ^b,c   Wellard, R Mark ^a,d   Werther, George A ^b,e   Cameron, Fergus J ^b,e   Finch, Sue J ^f   Papoutsis, Jennifer ^b   Northam, Elisabeth A ^b,e,f  

^a AUSTIN HEALTH   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGICAL PARAMETERS; REGRESSION ANALYSIS; SEX RATIO; SOCIAL STATUS; T2 RELAXATION TIME;

ADOLESCENT; ADULT; AGE FACTORS; BRAIN; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84859028498     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1290     Document Type: Article

References (28)

1. McCall AL, Figlewicz DP. How does diabetes mellitus produce brain dysfunction. Diabetes Spectrum 1997;10:25-32
2. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 2008;9: 36-45 (Pubitemid 350295687)
3. McIntyre RS, Kenna HA, Nguyen HT, et al. Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? Adv Ther 2010;27:63-80
4. Sima AAF. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010;47:279-293
5. Perantie DC, Wu J, Koller JM, et al. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007;30:2331-2337 (Pubitemid 47359042)
6. Gaudieri PA, Chen R, Greer TF, Holmes CS. Cognitive function inchildren with type 1 diabetes: a meta-analysis. Diabetes Care 2008;31:1892-1897
7. Northam EA, Rankins D, Lin A, et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009;32:445-450
8. Ashburner J, Friston KJ. Voxel-based morphometrydthe methods. Neuroimage 2000;11:805-821
9. Pell GS, Briellmann RS, Waites AB, Abbott DF, Jackson GD. Voxel-based relaxometry: anew approach for analysis of T2 relaxometry changes in epilepsy. Neuroimage 2004;21:707-713 (Pubitemid 38229933)
10. Pell G, Briellmann R, Abbott D, Jackson G. Optimization of VBM parameters for the detection of hippocampal sclerosis. In: 13th Annual Meeting of the International Society for Magnetic Resonance in Medicine. Miami Beach, Florida, International Society for Magnetic Resonance in Medicine, 2005, p. 1202
11. Courchesne E, Chisum HJ, Townsend J, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000;216:672-682 (Pubitemid 30660837)
12. Haacke EM, Miao Y, Liu M, et al. Correlation of putative iron content as represented by changes in R2*and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging 2010;32: 561-576
13. Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Elevated iron indices inpatients with diabetes. Diabet Med 2004;21: 798-802 (Pubitemid 38916230)
14. Leoncini S, Rossi V, Signorini C, Tanganelli I, Comporti M, Ciccoli L. Oxidative stress, erythrocyte ageing and plasmanon-protein-bound iron in diabetic patients. Free Radic Res 2008;42:716-724
15. Biessels GJ, van der Heide LP, Kamal A, Bleys RLAW, Gispen WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1-14 (Pubitemid 34465684)
16. Aye T, Reiss AL, Kesler S, et al. The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 2011; 34:1458-1462
17. Musen G, Lyoo IK, Sparks CR, et al. Effects of type 1diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006;55:326-333 (Pubitemid 43343260)
18. Ryan CM. Why iscognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes 2006;7:289-297 (Pubitemid 44593931)
19. Levitt HE, Cyphert TJ, Pascoe JL, et al. Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice. Diabetologia 2011;54:572-582
20. Fiordaliso F, Leri A, Cesselli D, et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001;50:2363-2375 (Pubitemid 33641924)
21. Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 2006;70:1076-1081 (Pubitemid 44161749)
22. Kamal A, Biessels GJ, Duis SE, Gispen WH. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000;43:500-506 (Pubitemid 30237960)
23. Brands AM, Biessels GJ, de Haan EHF, Kappelle LJ, Kessels RPC. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005;28: 726-735 (Pubitemid 40315341)
24. Stiles MC, Seaquist ER. Cerebral structural and functional changes in type 1 diabetes. Minerva Med 2010;101:105-114
25. Lin A, Northam EA, Rankins D, Werther GA, Cameron FJ. Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr Diabetes 2010;11:235-243
26. Lenroot RK, Giedd JN. Brain development inchildren and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev 2006;30:718-729 (Pubitemid 44292283)
27. Lupien SB, Bluhm EJ, Ishii DN. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J Neurosci Res 2003;74:512-523 (Pubitemid 37352073)
28. Revsin Y, Rekers NV, Louwe MC, et al. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetesmice. Neuropsychopharmacology 2009;34:747-758